Dr. McMeekin is the Acting Associate Commissioner for Regulatory Affairs (ACRA) within the Office of Regulatory Affairs (ORA) in the Food and Drug Administration (FDA). She has responsibility for over 5,000 staff and operations in ORA. ORA is FDA’s “field force” supporting FDA’s product centers through responsibilities including, inspections and investigations, including criminal investigations, compliance and enforcement, import operations, regulatory science and field laboratory operations. ORA also works closely with global, federal, state, local, tribal and territorial partners, and administers contracts, grants and cooperative agreements to advance an integrated system and ensure an effective public health safety net.
In her permanent role, Dr. McMeekin serves as the Deputy Associate Commissioner for Regulatory Affairs. In this role she is the principal advisor to and surrogate for the ACRA on the full range of ORA activities including enforcement, regulatory science implementation, import operations, global/federal/state collaborations, implementation of new laws and regulations, and overall strategic planning and prioritizations.
Dr. McMeekin previously served as the Acting Director of ORA’s Office of Strategic Planning and Operational Policy and as the Director, Division of Operational Policy. Prior to joining ORA, she served as Director, Division of Prescription Drugs in the Office of Compliance in the Center for Drug Evaluation and Research. Before joining FDA, she worked for the United States Pharmacopeia, and several health systems as a clinical pharmacist.
Dr. McMeekin received her Bachelor of Science degree in pharmacy and her Doctor of Pharmacy degree from Northeastern University in Boston, MA.